Biobanking Market Forecasts 2017-2027

LONDON, August 25, 2017 /PRNewswire/ --

Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Fluids and Stem Cells, Leading Biobanking Companies and Key Geographies

Biobanking - our new study reveals trends, R&D progress, and predicted revenues: 

Where is the Biobanking market heading? If you are involved in this sector you must read this brand new report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

Discover How to Stay Ahead: 

Our 259-page report provides 144 tables, charts, clearly illustrating the data presented in this research. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted drug sales at overall world market regional level, as well as giving a deep insight into the pipeline for Biobanking. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking market. See how to exploit these opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects: 

• In addition to revenue forecasting to 2027, our new study provides you with recent results, R&D overview, growth rates, and market shares.

• You will find original analyses, with business outlooks and developments.

• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and following Biobanking Submarkets: 

• Biobanking for Research

• Human Tissue

• Commercial

• Public

• Stem Cells

• Others (DNA, Blood fluids etc.)

Biobanking Market Forecasts 2017-2027: 

• Biobanking for Therapeutic Use

• Umbilical Cord Banking

• Adult Stem Cell Banking

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 12 leading national markets: 

• The US

• Germany

• France

• The UK

• Spain

• Italy

• The Netherlands

• Japan

• China

• India

• Brazil

• Russia

• RoW

Our analysis shows activities of biobanks, including these organisations: 

• Stemgent

• Biopta

• BioServe

• Coriell Institute for Medical Research

• Cord Blood America

• Cryo-Cell International.

And other companies, including these: 

• China Cord Blood Corp

• LifebankUSA

• ViaCord

• Cord Blood Registry

• Biogenea Pharmaceuticals

• StemLife

• Caladrius Biosciences.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth: 

Overall world revenue for Biobanking will surpass $53bn in 2027, our work calculates. This will be driven by the use of biobanking in drug development and medical research, as well as the expected rise in number of commercial biobanks over the forecast period

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Biobanking Market report helps you: 

In summary, our 259-page report provides you with the following knowledge:

• Revenue forecasts to 2027 for the Biobanking market and Leading Submarkets - discover the industry's prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2027 for 12 of the leading national markets - US, Germany, France, UK, Italy, Spain, Netherlands, Japan, Russia, China, India, Brazil

• Discussion of what stimulates and restrains companies and the market

• Prospects for established firms and those seeking to enter the market - including company profiles for 17 companies involved in commercial biobanking and biobanking for therapeutic use

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else: 

With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Biobanking market and leading companies. You will find data, trends and predictions.

Get our report today Biobanking Market Forecasts 2017-2027: Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Fluids and Stem Cells, Leading Biobanking Companies and Key Geographies. Avoid missing out - get our report now.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

Or click on https://www.visiongain.com/Report/1970/Biobanking-Market-Forecasts-2017-2027

List of Companies  

Abbott Laboratories

AIS

AKH Biobank

AllCells

American CryoStem

American Type Culture Collection

Analytical Biological Services

ARUP Laboratories

ASPREE Healthy Ageing Biobank

Assure Immune

Asterand

AstraZeneca

Aurora Biomed

Auto scribe Informatics

Bangalore Brain Bank

Barts Gynae Tissue Bank

Bayer

BBMRI

Beckman Coulter

BINDER

Bio Fortis

Bio Life Solutions

Bio Repository Resources

BioCision

Biogenea

Biomatrica

Biopta

BioreclamationIVT

BioRep

BioServe Biotechnologies

BioSHARE

Biovault Technical

BIOVIA

BrainNet Europe

Bristol-Myers Squibb

Brooks Automation (acquired Bio Storage Technologies)

Brooks Life Science Systems

Caladrius Biosciences

Cambridge Biomedical Research Centre

CARTaGENE

CCLG Tissue Bank

Cells4Life

Celltex Therapeutics

Cesca Therapeutics

China Cord Blood Corp.

China Kadoorie Biobank

CLB/Amsterdam Medical Center

CMD Biobank

CONCOR

CorCell

Cord Blood America

Cord Life

CORE Informatics

Coriell Institute for Medical Research

Cryo Bio System

Cryo-Cell

Cryo-Cell International

Cryogene Lab

CryoLogic

Cryo-Save

Cureline

Custom Biogenic Systems

Cybrdi

Cybrdi

DeCODE Genetics (Amgen)

Eli Lilly

ENGAGE

Eppendorf

Esco

ESFRI

Fisher Bio Services

FluidX

Future Health Biobank

GE Healthcare SeqWright Genomic Services

GEN2PHEN

Genentech

Gilson

GlaxoSmithKline

Haier Biomedical

Hamilton Robotics

Hamilton Storage Technologies

Hospital Necker Paris

Hudson Robotics

Hungarian Biobank

Huntington Disease Biobank

In biomed

Indivumed

Infectious Disease Biobank

IntegenX

International Stem Cell Corporation

Kaiser Permanente

King's College London Tissue Bank

Lab ware

LABVANTAGE

Leiden Longevity

Leiden University Medical Center

Life Bank USA

Life Gene

Life Lines Biobank

Malmӧ Microbiology Biobank

Merck

Micronics

Mitochondrial Disease Biobank

NESDA

Novare Biologistics

Novartis

Ocimum Bio solutions

OnCore UK

Organisation for Economic Co-operation and Development (OECD)

OriGene

Pacific Bio Storage

PALGA

Panasonic Biomedical

Parelsnoer

PerkinElmer

Pfizer

Pharma Cells

PHOEBE

Pop-Gen National Cohort

Precious Cells

Precision Bio services

PrecisionMed

PREVEND

Progenicyte

ProMedDx

ProteoGenex

Qiagen

Riken BRC Cell Bank

Roche

Sapien Biosciences

Scéil

Smart Cells

StarLIMS

Steelgate

Stem Life

Stem Save

Stemcyte

System Biosciences

Taiyo Nippon Sanso

TAP Bio systems (now owned by Sartorius Stedim Biotech)

TCG Life Sciences Tissue Bank

Tecan

Thermo Fisher Scientific

TISS-EU Project

Tissue Solutions

TTP Labtech

UCL Biobank

US Biomax

Via Cord

Virgin Health Bank

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

SOURCE Visiongain Ltd